TFF Pharmaceuticals (TFFP) Revenue & Revenue Breakdown
TFF Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$733.87K
Latest Revenue (Q)
$650.22K
TFF Pharmaceuticals Revenue by Period
TFF Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $733.87K | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
TFF Pharmaceuticals generated $733.87K in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
TFF Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $650.22K | 219.88% |
| 2024-03-31 | $203.27K | -72.30% |
| 2023-12-31 | $733.87K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | -100.00% |
| 2023-03-31 | $51.43K | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-09-30 | - | - |
TFF Pharmaceuticals generated $650.22K in revenue during Q2 2024, up 219.88% compared to the previous quarter, and up 1264.31% compared to the same period a year ago.
TFF Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TCRX | TScan Therapeutics | $21.05M | - |
| IMNM | Immunome | $14.02M | $2.36M |
| CUE | Cue Biopharma | $5.49M | $1.72M |
| TFFP | TFF Pharmaceuticals | $733.87K | $650.22K |
| ORGS | Orgenesis | $530.00K | $-292.00K |
| LIFE | aTyr Pharma | $353.00K | $235.00K |
| ANIX | Anixa Biosciences | $210.00K | - |
| GANX | Gain Therapeutics | $55.18K | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| ANTX | AN2 Therapeutics | - | - |
| INAB | IN8bio | - | - |
| CGTX | Cognition Therapeutics | - | - |
| DRMA | Dermata Therapeutics | - | - |
| ANVS | Annovis Bio | - | - |
| LTRN | Lantern Pharma | - | - |
| ONCR | Oncorus | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| INMB | INmune Bio | $-155.00K | - |
TFFP Revenue FAQ
What is TFF Pharmaceuticals’s yearly revenue?
TFF Pharmaceuticals's yearly revenue for 2023 was $733.87K, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TFFP's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is TFF Pharmaceuticals’s quarterly revenue?
TFF Pharmaceuticals's quarterly revenue for Q2 2024 was $650.22K, a 219.88% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $203.27K, a -72.30% decrease from the previous quarter (Q4 2023), and a 295.25% increase year-over-year (Q1 2023). TFFP's quarterly revenue for Q4 2023 was $733.87K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is TFF Pharmaceuticals’s revenue growth rate?
TFF Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.